Oncology Institute (TOIIW) Operating Leases (2022 - 2026)

Oncology Institute (TOIIW) has reported Operating Leases for 5 consecutive years, with $18.8 million the latest figure, recorded in Q1 2026.

• Operating Leases for Q1 2026 came in at $18.8 million, down 12.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (down 12.75% YoY), and the FY2025 annual result was $19.1 million, down 17.62% from the prior year.
• Operating Leases was $18.8 million for Q1 2026 at Oncology Institute, down from $19.1 million in the prior quarter.
• Over five years, Operating Leases peaked at $32.6 million in Q2 2023 and troughed at $14.6 million in Q2 2022.
• Average Operating Leases over 5 years is $23.6 million, with a median of $22.1 million recorded in 2022.
• Year-over-year, Operating Leases jumped 123.4% in 2023 and plunged 35.71% in 2025.
• Over 5 years, Operating Leases stood at $22.1 million in 2022, then climbed by 20.06% to $26.5 million in 2023, then retreated by 12.32% to $23.2 million in 2024, then retreated by 17.62% to $19.1 million in 2025, then fell by 1.51% to $18.8 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $18.8 million in Q1 2026, $19.1 million in Q4 2025, and $20.2 million in Q3 2025.